Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
5,297,462
Value
$1.00B
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of AZN by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,297,462$1.00B0.2%−683,949−11.4%ReducedHolders
Q1 20265,981,411$1.18B0.2%+4,542,013+315.5%AddedConverted for a 1-for-2 splitHolders
Q4 20252,878,796$264.6M0.1%+394,521+15.9%AddedHolders
Q3 20252,484,275$190.6M<0.1%+108,279+4.6%AddedHolders
Q2 20252,375,996$166.0M<0.1%+666,403+39.0%AddedHolders
Q1 20251,709,593$125.7M<0.1%−2,140,899−55.6%ReducedHolders
Q4 20243,850,492$252.3M0.1%+2,098,158+119.7%AddedHolders
Q3 20241,752,334$136.5M<0.1%−79,986−4.4%ReducedHolders
Q2 20241,832,320$142.9M<0.1%−64,050−3.4%ReducedHolders
Q1 20241,896,370$128.5M<0.1%−481,973−20.3%ReducedHolders
Q4 20232,378,343$160.2M0.1%+421,076+21.5%AddedHolders
Q3 20231,957,267$132.5M0.1%+171,480+9.6%AddedHolders
Q2 20231,785,787$127.8M0.1%+291,457+19.5%AddedHolders
Q1 20231,494,330$103.7M<0.1%+58,518+4.1%AddedHolders
Q4 20221,435,812$97.3M<0.1%+299,574+26.4%AddedHolders
Q3 20221,136,238$62.3M<0.1%+144,325+14.6%AddedHolders
Q2 2022991,913$65.5M<0.1%−160,959−14.0%ReducedHolders
Q1 20221,152,872$76.5M<0.1%+175,698+18.0%AddedHolders
Q4 2021977,174$56.9M<0.1%−15,311−1.5%ReducedHolders
Q3 2021992,485$59.6M<0.1%+91,142+10.1%AddedHolders
Q2 2021901,343$54.0M<0.1%+34,432+4.0%AddedHolders
Q1 2021866,911$43.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.